WITH BILLIONS OF DOLLARS ON THE LINE, ONE THING IS CERTAIN: Digital medicine is here to stay, and the number of stakeholders, from researchers to patients, will continue to grow as the promise of digital medicine becomes a reality.
Download Digital Medicine 2.0: The future is in policymaking, paying and protecting here.
As technology and regulation move forward, we need a better understanding of what lies ahead, how to fund it and how to protect the most important part of the equation: the patient. With perspectives from seventeen thought leaders in the digital health space, this newly released report, Digital Medicine 2.0, covers trends in digital medicine policy, financing, privacy and partnering. The report is presented with support from Demy-Colton, Digital Therapeutics Alliance, Evidation Health, Hogan Lovells, Rock Health and StartUp Health. Key themes include:
- Further defining digital medicine
- How partnerships are making the advancement of digital medicine possible
- Investment trends and funding the future of medicine
- The shifting regulatory environment and its impact
- The need for data security and how we can achieve this
The impact of the digital medicine industry is reflected in the comments of contributing thought leaders from top companies and organizations in the field, including Aliki Interactive, Digital Therapeutics Alliance, Evidation Health, Hogan Lovells, Medidata, MDIC, Michael J. Fox Foundation, NostaLab, Omada Health, PULSE, MassChallenge, Qualcomm Life, Roche, Rock Health, Sanofi, Stanford University, StartUp Health, U.S. FDA, and Verily.